Xeris Biopharma Holdings XERS
NASDAQ XERS
$16.52 +0.69 (+4.36%)
At close: Nov 11, 2026 · 4:00 PM EST

Xeris Biopharma Holdings (XERS) Price to FCF (2025 - 2026)

Updated

Xeris Biopharma Holdings' (XERS) Price to FCF was 24.29 for Q2 2026, up 17.8% from the prior quarter.

Analysis

Xeris Biopharma Holdings (XERS) Price to FCF (2025 - 2026) Analysis & Trends

For FY2025, Price to FCF at Xeris Biopharma Holdings was 45.58.

  • Five-year quarterly Price to FCF spans a low of 20.62 in Q1 2026 and a high of 127.62 in Q3 2025.
  • Per Business Quant data, the three quarters before Q2 2026 came in at 20.62 (Q1 2026), 45.58 (Q4 2025) and 127.62 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Xeris Biopharma Holdings 2.89 Bn 2.41 Bn 94.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 23.37
Jun 30, 2026 23.89
Mar 31, 2026 20.20
Dec 31, 2025 44.50
Sep 30, 2025 120.94
API Access

Xeris Biopharma Holdings Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=XERS&period=max&api_key=YOUR_API_KEY